Data gathered: December 26
Alternative Data for LivaNova
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 88 | Sign up | Sign up | Sign up | |
Sentiment | 100 | Sign up | Sign up | Sign up | |
Webpage traffic | 79,000 | Sign up | Sign up | Sign up | |
Employee Rating | 66 | Sign up | Sign up | Sign up | |
Google Trends | 34 | Sign up | Sign up | Sign up | |
Patents | 157 | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 45 | Sign up | Sign up | Sign up | |
Facebook Followers | 2,883 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 358 | Sign up | Sign up | Sign up | |
Twitter Followers | 6 | Sign up | Sign up | Sign up | |
Twitter Mentions | 10 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 1,420 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
Business Outlook | 39 | Sign up | Sign up | Sign up | |
Linkedin Employees | 3,176 | Sign up | Sign up | Sign up |
About LivaNova
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide.
Price | $47.14 |
Target Price | Sign up |
Volume | 62,100 |
Market Cap | $2.54B |
Year Range | $43.38 - $64.15 |
Dividend Yield | 0% |
PE Ratio | 108.72 |
Analyst Rating | 86% buy |
Industry | Medical Devices |
In the news
Franklin Resources Inc. Sells 537 Shares of LivaNova PLC (NASDAQ:LIVN)December 26 - ETF Daily News |
|
LivaNova PLC (NASDAQ:LIVN) Shares Purchased by Geode Capital Management LLCDecember 22 - ETF Daily News |
|
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova's VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant DepressionDecember 18 - Finnhub |
|
LivaNova (NASDAQ:LIVN) Raised to “Strong-Buy” at StockNews.comDecember 17 - ETF Daily News |
|
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant DepressionDecember 17 - Yahoo |
|
Captrust Financial Advisors Buys Shares of 4,133 LivaNova PLC (NASDAQ:LIVN)December 16 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q3 '24 | 318M | 226M | 225M | 33M | 54M | 0.900 |
Q2 '24 | 316M | 237M | 219M | 16M | 20M | 0.930 |
Q1 '24 | 253M | 231M | 207M | -42M | -14M | 0.730 |
Q4 '23 | 294M | 265M | 190M | 16M | -72M | 0.870 |
Q3 '23 | 272M | 219M | 202M | -7.3M | 19M | 0.730 |
Insider Transactions View All
Bianchi Francesco filed to sell 7,522 shares at $51. December 13 '24 |
Bianchi Francesco filed to sell 8,772 shares at $46.6. September 13 '24 |
Moore Daniel Jeffrey filed to sell 27,534 shares at $61.1. June 5 '24 |
Moore Daniel Jeffrey filed to sell 29,579 shares at $60.1. June 5 '24 |
McDonald Damien filed to sell 111,847 shares at $42.6. April 28 '23 |
Similar companies
Read more about LivaNova (LIVN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of LivaNova?
The Market Cap of LivaNova is $2.54B.
What is LivaNova's PE Ratio?
As of today, LivaNova's PE (Price to Earnings) ratio is 108.72.
What is the current stock price of LivaNova?
Currently, the price of one share of LivaNova stock is $47.14.
How can I analyze the LIVN stock price chart for investment decisions?
The LIVN stock price chart above provides a comprehensive visual representation of LivaNova's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LivaNova shares. Our platform offers an up-to-date LIVN stock price chart, along with technical data analysis and alternative data insights.
Does LIVN offer dividends to its shareholders?
As of our latest update, LivaNova (LIVN) does not offer dividends to its shareholders. Investors interested in LivaNova should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of LivaNova?
Some of the similar stocks of LivaNova are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.